Renovaro Biosciences
RENB
#8851
Rank
NZ$0.12 B
Marketcap
$0.78
Share price
-2.13%
Change (1 day)
-89.54%
Change (1 year)

Market capitalization of Renovaro Biosciences (RENB)

Market cap: NZ$0.12 Billion

As of September 2024 Renovaro Biosciences has a market cap of NZ$0.12 Billion. This makes Renovaro Biosciences the world's 8851th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Renovaro Biosciences from 2015 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.12 B-64.09%
2023NZ$0.33 B271.28%
2022NZ$90.04 M-83.93%
2021NZ$0.56 B192.09%
2020NZ$0.19 B-44.34%
2019NZ$0.34 B-14.83%
2018NZ$0.40 B340.68%
2017NZ$91.81 M344.74%
2016NZ$20.64 M-62.04%
2015NZ$54.38 M

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of Renovaro Biosciences was reported to be:

NZ$0.12 Billion
by Yahoo Finance info icon info icon
NZ$0.12 Billion
by CompaniesMarketCap info icon info icon
NZ$0.11 Billion
by Nasdaq info icon info icon